Elena Cant

Elena Cant Email and Phone Number

Fractional CEO and Executive Advisor @ Freelance
California, United States
Elena Cant's Location
San Francisco Bay Area, United States, United States
About Elena Cant

Pharma Services | BioPharma | BioTech | CDMO | MedTech | Diagnostics | Tool Manufacturing | Cell & Gene Therapy | Artificial Intelligence | Machine LearningElena is an accomplished business executive in Healthcare and Life Sciences with significant experience across a wide range of products, technologies, modalities, and geographies. Successful track record in establishing and growing businesses, functional groups, product portfolios, organic and M&A growth, integration and turnarounds in large public and small private companies. Passionate people leader that achieves strong followership among her teams and creates business culture that contributes to the business success. Effective executive, problem solver and collaborative thinker who even when moves into unfamiliar areas is skilled in synthesizing new knowledge to develop valuable insights, identifying and prioritizing opportunities, making decisions, and inspiring and empowering organization across functions and geographies for efficient delivery of substantial positive business impact. ~30 years of work experience, with ~20 years in healthcare/life sciences sector.Elena is currently serving as a Trustee on the Board of Trustees of the Pacific Northwest Research Institute (PNRI), a nonprofit biomedical research institute, where she is a member of its Business Development Committee governing licensing, IP strategy, corporate development, commercial strategy. Elena served as a Director on a public board of Societal CDMO (NASDAQ: SCTL) where she was a member of its Nominating and Governance and ESG Committees and an observer for its Audit and Compensation Committees.Elena holds an MBA from UofC Booth School of Business, completed Corporate Governance program at the Kellogg School of Management at Northwestern University and Women on Boards: Getting On and Adding Value program at Harvard T.H. Chan School of Public Health, received accreditation as a Professional Director - Public Company from the American College of Corporate Directors, and is currently an active member of the Corporate Board Member Network. Recipient of HBA Rising Start Award in 2017, and Hall of Femme award by Medical, Marketing and Media in 2018.Business Strategy | Governance | Private Equity | Business Growth | Transformation | Merger & Acquisitions (M&A) | Integration | Change Management | Go-To-Market (GTM) Strategy | P&L Ownership | Business Development | Business Planning | Manufacturing | Supply Chain | Product Strategy & Innovation | Organizational Structure | Business Operations | Talent Development | Partnerships

Elena Cant's Current Company Details
Freelance

Freelance

View
Fractional CEO and Executive Advisor
California, United States
Elena Cant Work Experience Details
  • Freelance
    Fractional Ceo And Executive Advisor
    Freelance
    California, United States
  • Pacific Northwest Research Institute
    Member Board Of Trustees
    Pacific Northwest Research Institute Dec 2024 - Present
    Seattle, Wa, Us
    Pacific Northwest Research Institute (PNRI) is a nonprofit biomedical research institute that unravels the powerful mysteries of the human genome to drive future medical breakthroughs and improve human health for generations to come (pnri.org).Member of Business Development Committee, which is governing licensing, IP strategy, business development and commercial strategy for PNRI.
  • Freelance
    Fractional Ceo And Executive Advisor
    Freelance Apr 2024 - Present
    Supporting a portfolio of newly forming companies in Healthcare and Life Sciences. Examples include:- Gather Together LLC - a new company with a mission of addressing epidemic of loneliness and isolation and improve quality of life in local communities by nurturing social in-person interactions.  Designing product and marketing strategy, developing business plan, seed fundraising. Overseeing a POC pilot in a few local communities in the East Bay Area.- Lark Therapeutics - a new company with a vision of developing clinical candidates that address unmet medical needs in the Inflammation and Immunology space. Led fundraising for lead optimization, IND submission, and phase 1 clinical development of a RIPK2 Type II small molecule kinase inhibitor development candidate with primary indication for Crohn’s disease and chronic pancreatitis. Developed fundraising strategy and pitch deck, revised program strategy, plans and budgets.
  • Societal™ Cdmo
    Board Member
    Societal™ Cdmo Sep 2022 - Apr 2024
    Gainesville, Georgia, Us
    Societal CDMO (NASDAQ: SCTL) was a public bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. - Member of Nominating and Governance Committee and ESG Committee.- Observer of Audit Committee and Compensation Committee.- Company was acquired by CoreRX, Inc in April 2024.
  • Culture Biosciences
    Chief Operating Officer And Chief Commercial Officer (Coo/Cco)
    Culture Biosciences 2022 - Apr 2024
    South San Francisco, Ca, Us
  • Twinstrand Biosciences
    Chief Operating Officer (Coo)
    Twinstrand Biosciences Jan 2020 - Sep 2022
  • Takeda Pharmaceuticals
    Commercial Head, Vaccine Business Unit
    Takeda Pharmaceuticals 2016 - 2019
    Tokyo, Jp
    Built a global commercial organization for commercialization of newly developed vaccines against infectious diseases with revenue potential >$1B internationally covering both public and private sectors.- Developed internal commercial capabilities, budget, resource plans, infrastructure, market access strategy, go-to-market strategies and operating model for global vaccine business on global, regional and local levels across US, APAC, LatAm, and Europe.- Managed key assets’ brand plans, global launch plans, integrated communication and advocacy plans, health economics modeling, global and local sales forecasting, competitive strategy and scenario planning, market assessments, analytics, commercial operations and excellence. - Led multi-channel and digital marketing strategy development based on a variety of market research activities, including segmentation analysis, payor and HCP research, affordability analysis, and competitive intelligence, in the US, Europe, Asia and LatAm countries. - Delivered consistently >20% of savings on annual basis by overseeing global functional budget and Profit and Loss, long-range and mid-range planning, annual commitments, budget tracking and LBEs. Enhanced vaccine portfolio and product pipeline by managing a number of financial and strategic evaluations and negotiations of potential partnerships and Mergers and Acquisitions targets.- Ensured coherent business strategy setting and execution by liaising with Medical Affairs, Regulatory, Discovery, Clinical Development, CMC, Manufacturing, Quality and other functions. - Served as a Chair of Global Vaccine Pricing Committee and a voting member of Executive Committee, Management Committee, Development Committee, and Business Development Committee of Vaccine Business Unit.
  • Takeda Pharmaceuticals
    Vp, Global Head Of Vaccine Business Operations
    Takeda Pharmaceuticals 2012 - 2016
    Tokyo, Jp
    Built new global vaccine business for Takeda with newly established operations across 9 global locations, reaching 400 employees and an innovative vaccine portfolio with >$1B in potential global revenue - Led successful integration of two acquisitions of bio tech start-ups with total value of >$300M and ~90 employees, thus directly contributing to the buildup of newly established global vaccine portfolio and creation of Takeda’s global Vaccine business. - Set up and coordinated business management and governance infrastructure, including Management Committee, Business Operations Committee, Vaccines Systems Committee, License Management Committee, and Vaccines Leadership Team. - Designed VBU org structure, developed and implemented processes and tools for employee recruitment, onboarding, training, engagement, and communication for the new Business Unit.- Built VBU Business Operations function to provide sustainable support to daily activities and global initiatives for effective and efficient business operations across nine VBU locations. - Contributed to $15-20M annual savings while processing on average 800 contracts per year. by identifying the need, designing, implementing, and managing global contracting process and tools to support heavily outsourced activities of VBU. Later the process got adopted in other parts of Takeda. - Oversaw infrastructure build up for proper functioning of VBU offices and labs across all its locations. - Led planning and implementation of business consolidation of four US locations into one global headquarter in Boston.
  • Hospira
    Head, Global Operations Strategy
    Hospira 2010 - 2012
    Lake Forest, Il, Us
    Set up and managed Manufacturing Operations Strategy group directly working for the Head of Operations to establish long-term operations strategy for generic injectables, biosimilars and medical devices on a global scale; developed Strategy Maps and Balanced Scorecards to execute and monitor the established goals.- Led annual strategic planning process and coordinated development of the financial long-range plan across all functions within Operations and Quality organizations.- Evaluated Hospira’s global network strategies, and developed financial evaluation, recommendations and strategic action plans for operations and manufacturing of various injectable pharmaceuticals product families, including biosimilars, betalactams, cytotoxics, drug delivery systems, IV solutions, medical devices and consumables.- Improved the sales and volume growth in each region by collaborating with the commercial regions to identify and prioritize cross-functional focus on product competitiveness and leading the Cost Competitiveness Council.- Supported analysis and due diligence of M&A targets, evaluated strategies for vertical integration, developed business cases for Greenfield, Brownfield and JV opportunities as well as for Make versus Buy decisions.
  • Mead Johnson Nutrition
    Associate Director, Strategy & Corporate Development
    Mead Johnson Nutrition 2009 - 2010
    Makati, National Capital Region, Ph
    Analyzed market opportunities across BRIC countries (Brazil, Russia, India, China); performed evaluation of potential acquisition targets and provided recommendations on MJN action/response.- Evaluated growth opportunities, designed financial model and formulated market sizing approach for product expansion in China; contributed strategic vision to the 5-year expansion business plan.- Supported due diligence and formation of the strategic JV with $7B food company in Middle East.- Designed and managed a new Competitive Intelligence process, established and led a Global Competitive Intelligence Team to provide monthly insights to MJN executives.
  • Mckinsey & Company
    Engagement Manager
    Mckinsey & Company 2005 - 2009
    Us
    Managed cross-functional teams to solve strategic, marketing, organizational, supply chain and operational business problems at pharmaceutical companies, hospitals, and payor organizations in the US and Globally. Articulated project plans and objectives, built client capabilities, and managed resources to achieve the desired impact.
  • Ibm Business Consulting Services/Pwc Consulting; Netherlands Economic Institute; Ntua
    Senior Consultant
    Ibm Business Consulting Services/Pwc Consulting; Netherlands Economic Institute; Ntua 1996 - 2003
  • Private School Of English For Children In Moldova
    Founder, Executive Manager
    Private School Of English For Children In Moldova 1994 - 1996

Elena Cant Education Details

  • The University Of Chicago Booth School Of Business
    The University Of Chicago Booth School Of Business
    Marketing
  • Harvard T.H. Chan School Of Public Health
    Harvard T.H. Chan School Of Public Health
    Women On Boards: Getting On And Adding Value
  • Kellogg Executive Education
    Kellogg Executive Education
    Corporate Governance
  • Techincal University Of Moldova
    Techincal University Of Moldova
    Economics And Management In Packaged Food & Beverages Industry

Frequently Asked Questions about Elena Cant

What company does Elena Cant work for?

Elena Cant works for Freelance

What is Elena Cant's role at the current company?

Elena Cant's current role is Fractional CEO and Executive Advisor.

What schools did Elena Cant attend?

Elena Cant attended The University Of Chicago Booth School Of Business, Harvard T.h. Chan School Of Public Health, Kellogg Executive Education, Techincal University Of Moldova.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.